Toxicity-reducing effect of compatibility of Tripterygium and licorice in animals: systematic review.
10.19540/j.cnki.cjcmm.20181214.002
- Author:
Hui-Zhen LI
1
;
Bin LIU
1
;
Hai-Yang SHU
2
;
Rui-Li YUAN
3
;
Xin-Yu JI
1
;
Han HU
3
;
Xiang MENG
1
;
Yu-Qi LIU
1
;
Nan-Nan SHI
1
;
Yan-Ping WANG
1
;
Cheng LYU
1
Author Information
1. Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences Beijing 100700,China.
2. Second Clinical Medical College,Guangzhou University of Chinese Medicine Guangzhou 510000,China.
3. Shaanxi University of Chinese Medicine Xianyang 712000,China.
- Publication Type:Journal Article
- Keywords:
Tripterygium wilfordii;
animal experiment;
hepatotoxicity;
licorice;
systematic review
- MeSH:
Animals;
Chemical and Drug Induced Liver Injury;
prevention & control;
Drugs, Chinese Herbal;
administration & dosage;
toxicity;
Glycyrrhiza;
Glycyrrhizic Acid;
administration & dosage;
Tripterygium;
chemistry;
toxicity
- From:
China Journal of Chinese Materia Medica
2019;44(16):3512-3519
- CountryChina
- Language:Chinese
-
Abstract:
The aim of this paper was to systematically evaluate the toxicity-reducing effect of Tripterygium-licorice in animal experiments,and also to provide evidence for basic research on the toxicity reduction of Tripterygium wilfordii. The PubMed,EMbase,Web of Science,CBM,CNKI and Wan Fang Databases from their establishment to August 31 th,2018 were searched. Two independent reviewers screened the papers,extracted the data,assessed the risk of bias using SYRCLE assessment tool and conducted Meta-analysis with Rev Man 5. 3 software. A total of 10 papers involving 31 studies were finally included,15 studies of which were used for Meta-analysis. Four studies were included for chronic hepatotoxicity animal model. In experimental group( 34 animals),Tripterygium was administered at dose of 0. 09-0. 1 mg·kg-1·d-1,and glycyrrhizic acid was administered at dose of 90-100 mg·kg-1,both for 2 weeks; in control group( 34 animals),glycyrrhizic acid was replaced with equal volume of normal saline. Eleven studies were included for acute hepatotoxicity animal model. In experimental group( 66 animals),glycyrrhizic acid was administered at dose of 75-480 mg·kg-1 for 7 days,then glycyrrhizic acid was stopped,and Tripterygium began to be administered at dose of 0. 6-1. 0 mg·kg-1 per 24 h or 48 h for a total of 1-2 times; in control group( 66 animals),glycyrrhizic acid was replaced with equal volume of normal saline or corresponding solvent. The results of Meta-analysis showed that in both chronic hepatotoxicity animal model and acute hepatotoxicity animal model,the transaminase levels in the experimental group were lower than those in the control group( P < 0. 05). Subgroup analysis of acute hepatotoxicity animal model showed that the transaminase levels in the experimental group were lower than those in the control group for every subgroup except " glycyrrhizic acid 75 mg·kg-1" subgroup. However,in terms of the mean difference( MD) and confidence interval( CI),there was no significant difference in transaminase decline between each subgroup. Low dose of glycyrrhizic acid( 90-100 mg·kg-1) has a toxicity-reduction effect on chronic hepatotoxicity induced by tripterygium( 0. 09-0. 10 mg·kg-1). Middle and high doses of glycyrrhizic acid( 120-480 mg·kg-1) have a toxicity-reduction effect on acute hepatotoxicity induced by tripterygium( 0. 6-1. 0 mg·kg-1),but with no significant dose-effect relationship.
